Elham Sajjadi Selected Research

Triple Negative Breast Neoplasms

4/2022

Low-risk triple-negative breast cancers: Clinico-pathological and molecular features.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elham Sajjadi Research Topics

Disease

18	Neoplasms (Cancer) 06/2022 - 07/2019
14	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2020
4	Microsatellite Instability 01/2022 - 01/2020
2	Turcot syndrome 01/2022 - 02/2020
2	Carcinogenesis 10/2021 - 01/2021
2	Multiple Sclerosis 02/2017 - 01/2016
1	Disease Progression 04/2022
1	Triple Negative Breast Neoplasms 04/2022
1	Pain (Aches) 12/2021
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 05/2021
1	Stomach Neoplasms (Stomach Cancer) 04/2021
1	Bone Resorption 01/2021
1	Breast Cancer Lymphedema 01/2020
1	Relapsing-Remitting Multiple Sclerosis 01/2016
1	Pre-Eclampsia (Preeclampsia) 07/2014
1	Gestational Diabetes (Gestational Diabetes Mellitus) 07/2014
1	Infections 05/2014

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
4	Biological ProductsIBA 04/2022 - 01/2020
3	Hormones (Hormone)IBA 04/2022 - 05/2021
3	Estrogen ReceptorsIBA 01/2022 - 02/2020
3	B7-H1 AntigenIBA 01/2022 - 01/2020
3	TensinsIBA 10/2021 - 01/2020
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2021
2	Aromatase InhibitorsIBA 12/2021 - 01/2021
1	Chemokine ReceptorsIBA 06/2022
1	Interleukin Receptors (Interleukin Receptor)IBA 06/2022
1	salicylhydroxamic acid (SHAM)IBA 12/2021
1	Phenobarbital (Luminal)FDA Link 12/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2021
1	Bone Density Conservation AgentsIBA 01/2021
1	pembrolizumabIBA 07/2019
1	InterferonsIBA 02/2017
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2016
1	Hemoglobins (Hemoglobin)IBA 07/2014
1	Albendazole (Albenza)FDA Link 05/2014

Therapy/Procedure

9	Therapeutics 01/2022 - 02/2017
6	Immunotherapy 01/2022 - 01/2020
1	Exercise Therapy (Therapy, Exercise) 01/2021
1	Mastectomy (Mammectomy) 01/2021
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Precision Medicine 01/2020